GenomeWeb Top 40 Rises 2 Percent in September, Largely Tracking Broader Market
Of the 40 firms tracked by GenomeWeb, 21 saw their stock prices rise month over month and 19 saw their shares decrease in value.
The Temperature-Activated Generation of Signal (TAGS) technology was developed by Roche for its high-throughput PCR-based instruments.
The firm last week announced it received funding that will allow it to complete development of the test, called Myelo-Scan, by the end of 2026.
23andMe CEO Wojcicki Not Open to Third-Party Takeover Proposals
In a regulatory filing, 23andMe CEO Anne Wojcicki issued a brief statement reiterating that she sees taking the company private as the "best path."
Qiagen Targets Oncohematology, Companion Diagnostics Space With Clinical Digital PCR Instrument
Premium
The firm launched the QiAcuityDx system on Monday and will seek US Food and Drug Administration 510(k) clearance along with a BCR-ABL assay.
FDA Breakthrough Device Designation Moves Inbiome's 'Molecular Culture' Toward Clinical Market
Premium
The PCR and AI-based method from Dutch microbiology diagnostics developer Inbiome can identify more than 200 bacterial organisms in less than four hours.